Pal, Sumanta K ;
Rosenberg, Jonathan E ;
Hoffman-Censits, Jean H...
Pal , S K , Rosenberg , J E , Hoffman-Censits , J H , Berger , R , Quinn , D I , Galsky , M D , Wolf , J , Dittrich , C , Keam , B , Delord , J-P , Schellens , J H M , Gravis , G , Medioni , J , Maroto , P , Sriuranpong , V , Charoentum , C , Burris , H A , Grünwald , V , Petrylak , D , Vaishampayan , U , Gez , E , de Giorgi , U , Lee , J-L , Voortman , J , Gupta , S , Sharma , S , Mortazavi , A , Vaughn , D J , Isaacs , R , Parker , K , Chen , X , Yu , K , Porter , D , Porta , D G & Bajorin , D F 2018 , ' Efficacy of BGJ398, a fibroblast growth factor receptor 1–3 inhibitor, in patients with previously treated advanced urothelial carcinoma with FGFR3 alterations ' , Cancer discovery , vol. 8 , no. 7 , pp. 812-821 . https://doi.org/10.1158/2159-8290.CD-18-0229.
,
2018